Amitriptyline reverses hyperalgesia and improves associated mood-like disorders in a model of experimental monoarthritis

Behavioural Brain Research

Volumn 265, Issue , 2014, Pages 12-21

  Amorim, D ^a,b   David Pereira, A ^a,b   Pertovaara, A ^c   Almeida, A ^a,b   Pinto Ribeiro, F ^a,b  

^a UNIVERSITY OF MINHO   (Portugal)

^b UNIVERSITY OF MINHO   (Portugal)

^c UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Amitriptyline; Experimental monoarthritis; Mechanical hyperalgesia; Pain mood disorders comorbidity

Indexed keywords

AMITRIPTYLINE;

ANHEDONIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY DISORDER; ARTICLE; CHRONIC PAIN; CLIMBING; COMORBIDITY; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; DRUG MECHANISM; ELEVATED PLUS MAZE TEST; FORCED SWIM TEST; HYPERALGESIA; IMMOBILITY; LATENT PERIOD; LOCOMOTION; MALE; MONARTHRITIS; MOOD DISORDER; NOCICEPTION; NONHUMAN; OPEN FIELD TEST; PHENOTYPE; PRIORITY JOURNAL; RAT; TASK PERFORMANCE; TREATMENT RESPONSE;

AMITRIPTYLINE; EXPERIMENTAL MONOARTHRITIS; MECHANICAL HYPERALGESIA; PAIN-MOOD DISORDERS COMORBIDITY;

AMITRIPTYLINE; ANALGESICS, NON-NARCOTIC; ANIMALS; ARTHRITIS; CARRAGEENAN; DISEASE MODELS, ANIMAL; EXPLORATORY BEHAVIOR; FOOD PREFERENCES; HYPERALGESIA; KAOLIN; MALE; MAZE LEARNING; MOOD DISORDERS; MOTOR ACTIVITY; PAIN THRESHOLD; PHYSICAL STIMULATION; RATS; RATS, WISTAR; SWIMMING;

EID: 84894792888     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2014.02.003     Document Type: Article

References (57)

1. Stange K.C., Zyzanski S.J., Jaen C.R., Callahan E.J., Kelly R.B., Gillanders W.R., et al. Illuminating the 'black box'. A description of 4454 patient visits to 138 family physicians. J Fam Pract 1998, 46:377-389.
2. Sherbourne C.D., Asch S.M., Shugarman L.R., Goebel J.R., Lanto A.B., Rubenstein L.V., et al. Early identification of co-occurring pain, depression and anxiety. J Gen Intern Med 2009, 24(5):620-625.
3. Bair M.J., Robinson R.L., Katon W., Kroenke K. Depression and pain comorbidity: a literature review. Arch Intern Med 2003, 163(20):2433-2445.
4. Fernandez-Guasti A., Reyes R., Martinez-Mota L., Lopez-Munoz F.J. Influence of inflammatory nociception on the anxiolytic-like effect of diazepam and buspironein rats. Psychopharmacology (Berl) 2005, 180:399-407.
5. Narita M., Kaneko C., Miyoshi K., Nagumo Y., Kuzumaki N., Nakajima M., et al. Chronic pain induces anxiety with concomitant changes in opioidergic function in the amygdala. Neuropsychopharmacology 2006, 31:739-750.
6. Jimenez-Velazquez G., Lopez-Munoz F.J., Fernandez-Guasti A. Parallel anxiolytic-like and antinociceptive actions of diazepam in the anterior basolateral amygdala and dorsal periaqueductal gray. Brain Res 2010, 1349:11-20.
7. Parent A.J., Beaudet N., Beaudry H., Bergeron J., Bérubé P., Drolet G., et al. Increased anxiety-like behaviors in rats experiencing chronic inflammatory pain. Behav Brain Res 2012, 229(1):160-167.
8. Yalcin I., Bohren Y., Waltisperger E., Sage-Ciocca D., Yin J.C., Freund-Mercier M.J., et al. A time-dependent history of mood disorders in a murine model of neuropathic pain. Biol Psychiatry 2011, 70:946-953.
9. Twillman R.K. Mental disorders in chronic pain patients. J Pain Palliat Care Pharmacother 2007, 21:13-19.
10. Teh C.F., Zaslavsky A.M., Reynolds C.F., Cleary P.D. Effect of depression treatment on chronic pain outcomes. Psychosom Med 2010, 72(1):61-67.
11. Jann M.W., Slade J.H. Antidepressant agents for the treatment of chronic pain and depression. Pharmacotherapy 2007, 27(11):1571-1587.
12. Moore R.A., Derry S., Aldington D., Cole P., Wiffen P.J. Amitriptyline for neuropathic pain and fibromyalgia in adults. Cochrane Database Syst Rev 2012, 12:CD008242.
13. Mochizucki D. Serotonin and noradrenaline reuptake inhibitors in animal models of pain. Hum Psychopharmacol 2004, 19(Suppl. 1):S15-S19.
14. Pinto-Ribeiro F., Ansah O.B., Almeida A., Pertovaara A. Response properties of nociceptive neurons in the caudal ventrolateral medulla (CVLM) in monoarthritic and healthy control rats: modulation of responses by the paraventricular nucleus of the hypothalamus (PVN). Brain Res Bull 2011, 86:82-90.
15. Radhakrishnan R., Moore S.A., Sluka K.A. Unilateral carrageenan injection into muscle or joint induces chronic bilateral hyperalgesia in rats. Pain 2003, 104:567-577.
16. Randall L.O., Selitto J.J. A method for measurement of analgesic activity on inflamed tissue. Arch Int Pharmacodyn Ther 1957, 111:409-419.
17. Rivat C., Richebé P., Laboureyras E., Laulin J.P., Havouis R., Noble F., et al. Polyamine deficient diet to relieve pain hypersensitivity. Pain 2008, 137:125-137.
18. Barton N.J., Strickland I.T., Bond S.M., Brash H.M., Bate S.T., Wilson A.W., et al. Pressure application measurement (PAM): a novel behavioural technique for measuring hypersensitivity in a rat model of joint pain. J Neurosci Methods 2007, 163(1):67-75.
19. Leite-Almeida H., Almeida-Torres L., Mesquita A.R., Pertovaara A., Sousa N., Cerqueira J.J., et al. The impact of age on emotional and cognitive behaviours triggered by experimental neuropathy in rats. Pain 2009, 144:57-65.
20. Ennaceur A., Michalikova S., Chazot P.L. Models of anxiety: responses of rats to novelty in an open space and an enclosed space. Behav Brain Res 2006, 171:26-49.
21. Bessa J.M., Mesquita A.R., Oliveira M., Pêgo J.M., Cerqueira J.J., Palha J.A., et al. A trans-dimensional approach to the behavioral aspects of depression. Front Behav Neurosci 2009, 3:1.
22. Slattery D.A., Cryan J.F. Using the rat forced swim test to assess antidepressant-like activity in rodents. Nat Protoc 2012, 7(6):1009-1014.
23. Ottoni E.B. EthoLog 2.2 - a tool for the transcription and timing of behavior observation sessions. Behav Res Methods Instrum Comput 2000, 32(3):446-449.
24. Rénéric J.P., Bouvard M., Stinus L. In the rat forced swimming test, chronic but not subacute administration of dual 5-HT/NA antidepressant treatments may produce greater effects than selective drugs. Behav Brain 2002, 136(2):521-532.
25. Neugebauer V., Han J.S., Adwanikar H., Fu Y., Ji G. Techniques for assessing knee joint pain in arthritis. Mol Pain 2007, 3:8.
26. Neugebauer V. Arthritis model, kaolin-carrageenan induced arthritis (knee). Encyclopedia of pain 2007, 115-118. Springer-Verlag, Berlin Heidelberg. R.F. Schmidt, W.D. Willis (Eds.).
27. Lu Y., Westlund K.N. Gabapentin attenuates nociceptive behaviors in an acute arthritis model in rats. J Pharmacol Exp Ther 1999, 290(1):214-219.
28. Ji G., Fu Y., Ruppert K.A., Neugebauer V. Pain-related anxiety-like behavior requires CRF1 receptors in the amygdala. Mol Pain 2007, 3:13.
29. Kim K.S., Kim M.H., Yeom M., Choi H.M., Yang H.I., Yoo M.C., et al. Arthritic disease is more severe in older rats in a kaolin/carrageenan-induced arthritis model. Rheumatol Int 2011, 32:3875-3879.
30. Pearson R.G., Kurien T., Shu K.S., Scammell B.E. Histopathology grading systems for characterisation of human knee osteoarthritis-reproducibility, variability, reliability, correlation, and validity. Osteoarthr Cartilage 2011, 19(3):324-331.
31. Axford J., Butt A., Heron C., Hammond J., Morgan J., Alavi A., et al. Prevalence of anxiety and depression in osteoarthritis: use of the Hospital Anxiety and Depression Scale as a screening tool. Clin Rheumatol 2010, 29(11):127712-127783.
32. Kim H., Chen L., Lim G., Sung B., Wang S., McCabe M.F., et al. Brain indoleamine 2,3-dioxygenase contributes to the comorbidity of pain and depression. J Clin Invest 2012, 122:2940-2954.
33. Brandt K.D. Animal models of osteoarthritis. Biorheology 2002, 39(1-2):221-235.
34. Wessel J. The reliability and validity of pain threshold measurements in osteoarthritis of the knee. Scand J Rheumatol 1995, 24:238-242.
35. Zhang W., Moskowitz R.W., Nuki G., Abramson S., Altman R.D., Arden N., et al. OARSI recommendations for the management of hip and knee osteoarthritis, part II: OARSI evidence-based, expert consensus guidelines. Osteoarthr Cartilage 2008, 16:137-162.
36. Neugebauer V., Schaible H.G. Evidence for a central component in the sensitization of spinal neurons with joint input during development of acute arthritis in cat's knee. J Neurophysiol 1990, 64:299.
37. Neugebauer V., Rumenapp P., Schaible H.G. The role of spinal neurokinin-2 receptors in the processing of nociceptive information from the joint and in the generation and maintenance of inflammation-evoked hyperexcitability of dorsal horn neurons in the rat. Eur J Neurosci 1996, 8:249-260.
38. Castagné V., Moser P., Roux S., Porsolt R.D. Rodent models of depression: forced swim and tail suspension behavioral despair tests in rats and mice. Curr Protoc Neurosci 2011, Chapter 8:Unit 8.10A.
39. Wang J., Goffer Y., Xu D., Tukey D.S., Shamir D.B., Eberle S.E., et al. A single subanesthetic dose of ketamine relieves depression-like behaviors induced by neuropathic pain in rats. Anesthesiology 2011, 115(4):812-821.
40. Anisman H., Matheson K. Stress, depression, and anhedonia: caveats concerning animal models. Neurosci Biobehav Rev 2005, 29:525-546.
41. Matthews K., Forbes N., Reid I.C. Sucrose consumption as an hedonic measure following chronic unpredictable mild stress. Physiol Behav 1995, 57:241-248.
42. Fairweather D.B., Kerr J.S., Hilton S., Hindmarch I. A placebo controlled double-blind evaluation of the pharmacodynamics of fengabine vs amitriptyline following single and multiple doses in elderly volunteers. Br J Clin Pharmacol 1993, 35(3):278-283.
43. You L.Q., Liu J., Jia L., Jiang S.M., Wang G.Q. Effect of low-dose amitriptyline on globus pharyngeus and its side effects. World J Gastroenterol 2013, 19(42):7455-7460.
44. Nattel S. Frequency-dependent effects of amitriptyline on ventricular conduction and cardiac rhythm in dogs. Circulation 1985, 72(4):898-906.
45. Sasyniuk B.I., Jhamandas V., Valois M. Experimental amitriptyline intoxication: treatment of cardiac toxicity with sodium bicarbonate. Ann Emerg Med 1986, 15(9):1052-1059.
46. Bomholt S.F., Mikkelsen J.D., Blackburn-Munro G. Antinociceptive effects of the antidepressants amitriptyline, duloxetine, mirtazapine and citalopram in animal models of acute, persistent and neuropathic pain. Neuropharmacology 2005, 48(2):252-263.
47. Flake N.M., Gold M.S. Inflammation alters sodium currents and excitability of temporomandibular joint afferents. Neurosci Lett 2005, 384(3):294-299.
48. Pertovaara A. Noradrenergic pain modulation. Prog Neurobiol 2006, 80:53-83.
49. Richards B.L., Whittle S.L., van der Heijde D.M., Buchbinder R. The efficacy and safety of antidepressants in inflammatory arthritis: a Cochrane systematic review. J Rheumatol Suppl 2012, 90:21-27.
50. Cui M., Feng Y., McAdoo D.J., Willis W.D. Periaqueductal gray stimulation-induced inhibition of nociceptive dorsal horn neurons in rats is associated with the release of norepinephrine, serotonin, and amino acids. J Pharmacol Exp Ther 1999, 289(2):868-876.
51. Bräu M.E., Dreimann M., Olschewski A., Vogel W., Hempelmann G. Effect of drugs used for neuropathic pain management on tetrodotoxin-resistant Na(+) currents in rat sensory neurons. Anesthesiology 2001, 94(1):137-144.
52. Su X., Liang A.H., Urban M.O. The effect of amitriptyline on ectopic discharge of primary afferent fibers in the L5 dorsal root in a rat model of neuropathic pain. Anesth Analg 2009, 108(5):1671-1679.
53. Dharmshaktu P., Tayal V., Kalra B.S. Efficacy of antidepressants as analgesics: a review. J Clin Pharmacol 2012, 52(1):6-17.
54. Li Y., Raaby K.F., Sánchez C., Gulinello M. Serotonergic receptor mechanisms underlying antidepressant-like action in the progesterone withdrawal model of hormonally induced depression in rats. Behav Brain Res 2013, 256C:520-528.
55. Tatsumi M., Groshan K., Blakely R.D., Richelson E. Pharmacological profile of antidepressants and related compounds at human monoamine transporters. Eur J Pharmacol 1997, 340:249-258.
56. Detke M.J., Rickels M., Lucki I. Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacology (Berl) 1995, 121(1):66-72.
57. Khairova R.A., Machado-Vieira R., Du J., Manji H.K. A potential role for pro-inflammatory cytokines in regulating synaptic plasticity in major depressive disorder. Int J Neuropsychopharmacol 2009, 12(4):561-578.